Skip to main content
logo
Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
115.50
0.00 (0.00%)
Aug 11, 2025, 8:00 PM EDT

Paramount Global Revenue

Novartis AG had revenue of $14.84B in the quarter ending June 30, 2025, with 15.26% growth. This brings the company's revenue in the last twelve months to $55.19B, up 12.95% year-over-year. In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth.

Revenue (ttm)
55.19B
Revenue Growth
+12.95%
P/S Ratio
4.18
Revenue / Employee
727.25K
Employees
75,883
Market Cap
230.64B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
American Oncology Network1.76B
Northwest Biotherapeutics1.47M
Silence Therapeutics27.17M
Global Cord Blood196.10M
Revenue Rankings

Novartis AG News

More News